These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 19952380)
1. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Cavezzi A; Tessari L Phlebology; 2009 Dec; 24(6):247-51. PubMed ID: 19952380 [TBL] [Abstract][Full Text] [Related]
2. Sclerotherapy and foam sclerotherapy for varicose veins. Coleridge Smith P Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382 [TBL] [Abstract][Full Text] [Related]
3. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes. Whiteley MS; Patel SB Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590 [TBL] [Abstract][Full Text] [Related]
4. An investigation into the influence of various gases and concentrations of sclerosants on foam stability. Peterson JD; Goldman MP Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095 [TBL] [Abstract][Full Text] [Related]
5. Review of published information on foam sclerotherapy. Stücker M; Kobus S; Altmeyer P; Reich-Schupke S Dermatol Surg; 2010 Jun; 36 Suppl 2():983-92. PubMed ID: 20590705 [TBL] [Abstract][Full Text] [Related]
6. Complications and side-effects of foam sclerotherapy. Guex JJ Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of published reports of foam sclerotherapy: what do we know conclusively? Myers KA; Roberts S Phlebology; 2009 Dec; 24(6):275-80. PubMed ID: 19952384 [TBL] [Abstract][Full Text] [Related]
13. Commentary: An investigation into the influence of various gases and concentrations of sclerosants on foam stability. Frullini A Dermatol Surg; 2011 Jan; 37(1):17-8. PubMed ID: 21214662 [No Abstract] [Full Text] [Related]
14. Foam and liquid sclerotherapy for varicose veins. Coleridge Smith P Phlebology; 2009; 24 Suppl 1():62-72. PubMed ID: 19307442 [TBL] [Abstract][Full Text] [Related]
15. Foam sclerotherapy for the treatment of superficial venous insufficiency. Gibson KD; Ferris BL; Pepper D Surg Clin North Am; 2007 Oct; 87(5):1285-95, xii-xiii. PubMed ID: 17936487 [TBL] [Abstract][Full Text] [Related]
16. Saphenous ablation: sclerosant or sclerofoam? Coleridge Smith P Semin Vasc Surg; 2005 Mar; 18(1):19-24. PubMed ID: 15791549 [TBL] [Abstract][Full Text] [Related]
17. Should foam made with physiologic gases be the standard in sclerotherapy? Wong M Phlebology; 2015 Oct; 30(9):580-6. PubMed ID: 25392457 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study". Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623 [TBL] [Abstract][Full Text] [Related]
19. Neurological and chest symptoms following sclerotherapy: a single centre experience. Hill DA Phlebology; 2014 Oct; 29(9):619-27. PubMed ID: 23945346 [TBL] [Abstract][Full Text] [Related]
20. A convenient source of carbon dioxide for sclerosant foams. Parsi K; Exner T; Connor DE; Joseph JE; Fung DD Dermatol Surg; 2006 Dec; 32(12):1533-4. PubMed ID: 17199670 [No Abstract] [Full Text] [Related] [Next] [New Search]